A 30-year-old female presented to Dr. Lixin Zhang at Dent Neurologic’s Dizziness, Balance, and Tinnitus Center with a complaint of headaches and dizziness. Three months ago she had her first vertigo attack; she felt like the room was spinning and got nauseous. Since then, she’s had five more of these major attacks each lasting over […]
The connection between dizziness (vertigo) & migraine history Read More »
A 60-year-old male patient presented to Dr. Lixin Zhang at Dent Neurologic’s Dizziness, Balance, and Tinnitus Center. He explained that sometimes he gets a loud ringing in his ear and his ear would feel plugged. Then, out of nowhere, it would feel like the entire room was spinning. He’d have to crawl to his bathroom
Should you talk to your doctor about Meniere’s Disease? Read More »
Hearing Aid Research Are you interested in participating in hearing aid research? Dr. Zhang is collaborating with Dr. Wei Sun at UB and is recruiting people over the age of 18 who have tinnitus and hearing loss. Participants will be compensated for their time. This study will require you to wear hearing aids for 3-4
Hearing Aid Research Read More »
Meniere’s Study Have you been diagnosed with Meniere’s Disease? Do you frequently experience vertigo? If you answered yes to these questions and are over the age of 18, you may qualify for a research study. Qualified participants will receive at no cost: All study-related exams Study drug or placebo (no active ingredient) If you are
Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
STARS and STARS Extension Read More »
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
LivaNova RECOVER VNS Read More »
A clinical research study is underway for people with focal epilepsy currently taking 1-3 anti-epileptic drugs that are still experiencing frequent seizures. Three doses of investigational drug are being studied and some participants will be assigned placebo. All participants will receive active study on the extension study.
PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects Inclusion Criteria Age 55-90 years Have a reliable study partner, an identified adult who has sufficient contact to knowledgeably report on the subject’s daily cognition, function, behavior, safety, compliance and adherence. Have a clinical diagnosis of mild-to-moderate AD Visual and
The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer’s disease.
